*Walter Bloomberg
*Walter Bloomberg
$MRNA
$MRNA shares -4.1% premarket after results and guidance
*Walter Bloomberg
*Walter Bloomberg @DeItaone · 
$MRNA Q4 & FY25 Outlook: 🔹 Q4 Results: • EPS: -$2.91 (Missed Est. -$2.68) • Revenue: $966M (Beat Est. $942.8M, -66% y/y) • COVID-19 Vaccine Rev: $923M (In Line) • Op. Loss: -$1.25B (Est. -$1.13B, vs. $6M profit y/y) • Cash & Equiv.: $1.93B (Est. $2.12B) 🔹 FY25 Guidance:
From X

Disclaimer: The above content reflects only the author's opinion and does not represent any stance of CoinNX, nor does it constitute any investment advice related to CoinNX.